Markets:

Overview

News

Currencies

International

Treasuries

Avidity Biosciences, Inc. - Common Stock (NQ:RNA)

72.89 +0.03 (+0.05%)

Streaming Delayed Price Updated: 12:42 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Avidity Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023

September 13, 2023

FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 13, 2023 – USA News Group – Sufferers of many different ailments saw reason to grow their hope in 2022 when the US Food...

Via FinancialNewsMedia

Stocks That Hit 52-Week Lows On Tuesday ↗

July 25, 2023

On Tuesday, 56 companies set new 52-week lows.

Via Benzinga

What 10 Analyst Ratings Have To Say About Avidity Biosciences ↗

May 17, 2023

Via Benzinga

Avidity Biosciences Touts Encouraging Data From Myotonic Dystrophy Type 1 Study ↗

April 28, 2023

Avidity Biosciences Inc (NASDAQ: RNA) announced

Via Benzinga

After Falling 18% in 1 Day, Is This Growth Stock Done For? ↗

April 11, 2023

It's too soon to predict doom, but that doesn't mean things are good.

Via The Motley Fool

Stocks That Hit 52-Week Lows On Monday ↗

September 11, 2023

Monday's session saw 175 companies set new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023 ↗

May 22, 2023

Via Benzinga

The Latest Analyst Ratings for Avidity Biosciences ↗

March 31, 2023

Via Benzinga

Expert Ratings for Avidity Biosciences ↗

March 31, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

September 07, 2023

On Thursday, 283 companies set new 52-week lows.

Via Benzinga

Where Avidity Biosciences Stands With Analysts ↗

August 09, 2023

Via Benzinga

Why Avidity Biosciences Shares Are Sliding Today ↗

March 30, 2023

Via Benzinga

Expert Ratings for Avidity Biosciences ↗

March 01, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

August 11, 2023

During the Friday's sesion, 157 stocks hit new 52-week lows.

Via Benzinga

FDA Eases Partial Hold On Avidity Biosciences' Investigational Drug Study In Type Of Dystrophy ↗

May 17, 2023

The FDA has eased the partial clinical hold on Avidity Biosciences Inc's (NASDAQ: RNA) AOC 1001, allowing Avidity to double the number of participants in the MARINA Open-Label Extension (MARINA-OLE)...

Via Benzinga

US Stocks Mixed; Amazon Posts Upbeat Results ↗

April 28, 2023

U.S. stocks traded mixed this morning, following the release of several earnings reports. Following the market opening Friday, the Dow traded up 0.11% to 33,863.22 while the NASDAQ fell 0.25% to...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

July 26, 2023

Wednesday saw 59 companies set new 52-week lows.

Via Benzinga

Ensysce Biosciences, AST SpaceMobile, IGM Biosciences And Other Big Stocks Moving Lower On Friday ↗

March 31, 2023

U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

July 24, 2023

On Monday morning, 70 companies achieved new lows for the year.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023 ↗

March 31, 2023

Via Benzinga

Why First Republic Bank Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 28, 2023

Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 268% to $3.42 after dropping around 8% on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 30, 2023

Via Benzinga

Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 30, 2023

Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...

Via Benzinga

Avidity Bio Crashes 26% After 'Rarer Than Rare' Event Sidelines Key Study ↗

March 30, 2023

The company is working on a treatment for an inherited muscle-wasting disease.

Via Investor's Business Daily

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 30, 2023

Via Benzinga

Analyst Says This Small Cap Biotech Firm Has 'Very Valuable Therapeutic,' Upgrades Stock ↗

February 27, 2023

Via Benzinga

CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks ↗

January 06, 2023

Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too.

Via Investor's Business Daily

Peering Into Avidity Biosciences's Recent Short Interest ↗

January 03, 2023

Avidity Biosciences's (NASDAQ:RNA) short percent of float has fallen 26.62% since its last report. The company recently reported that it has 6.51 million shares sold short, which is 11.33% of all...

Via Benzinga

EXCLUSIVE: The Benzinga Moneymaker Series, 5 Emerging Stocks For Investors To Watch ↗

December 15, 2022

Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. The rise of social media and retail traders gave way to countless methods to uncover new information....

Via Benzinga

Novavax, Tesla, Western Digital And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

December 15, 2022

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.